Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia.

Leukemia - 1 Apr 1998

Cortes J, Fayad L, Kantarjian H, O'Brien S, Lee M S, Talpaz M

Abstract excerpt

Twenty to 25% of patients with chronic myelogenous leukemia (CML) treated with interferon-alpha (IFN-A) achieve a complete cytogenetic response (CCR). However, cells bearing rearrangement of BCR/ABL can still be detected many years after achieving a CCR despite the absence of clinical evidence of active disease. It has been suggested that the disease is kept in a dormant state by immune mechanisms. How this is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to HLA Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Phenotype

Share to Recombinant Proteins

Share to Treatment Outcome

Source

Identifiers

PMID: 9557601
DOI: 10.1038/sj.leu.2400965

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia.PMID 9557601Read ↗

Human leukocyte antigens in Indian patients with chronic myeloid leukemia.Semantic proximity Read ↗

Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis.Semantic proximity Read ↗

Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease.Semantic proximity Read ↗

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosisSemantic proximity Read ↗

HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer.Semantic proximity Read ↗

HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.Semantic proximity Read ↗

Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome–positive chronic-phase chronic myeloid leukemia after failure of interferon-αSemantic proximity Read ↗

HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaSemantic proximity Read ↗

HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome.Semantic proximity Read ↗

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).Semantic proximity Read ↗

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α.Semantic proximity Read ↗

Analysis of molecular breakpoint and m‐RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.